Novartis deal for Chinook makes kidney-treatment competitors more attractive, analysts say By: MarketWatch June 12, 2023 at 15:40 PM EDT Travere Therapeutics and Vera Therapeutics are also developing treatments for rare kidney disease Read More >> Related Stocks: Chinook Therapeutics, Inc. - Common Stock Novartis AG Common Stock Travere Therapeutics, Inc. - Common Stock Vera Therapeutics, Inc. - Class A Common Stock
